Kendall Foster Email

Founder and CEO . GENIXUS

Current Roles

Employees:
27
Revenue:
$2.7M
About
Acute and critical care medicines help hospital staff save countless lives while under enormous pressure. Yet the space has seen precious little innovation for decades, leaving hospitals and patients at the mercy of outdated technologies. GENIXUS began in 2019 shortly after our founder visited the ICU with his two-week-old daughter and observed injections being administered with hand-written syringes. It seemed out of place in modern medicine. How, for instance, did they track the syringe? How could they be sure what was in it? And could quality be maintained? From his long experience in pharmaceutical and vaccine manufacturing, he knew there had to be a better way. The idea for GENIXUS was born: create a platform that brings together the brightest minds and latest innovations to reinvent how acute and critical care medicines are manufactured and delivered. Safeguarding what matters by bringing critical thinking to critical care.
GENIXUS Address
150 N Research Campus Dr
KANNAPOLIS, NC
GENIXUS Email

Past Companies

GENIXUSFounder and CEO
ApiJect Systems Corp.VP of Technical Operations
KymanoxPrincipal Advisor

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.